| 000 | 00965 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518092639.0 | ||
| 264 | 0 | _c20200921 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a2213-2619 | ||
| 024 | 7 |
_a10.1016/S2213-2600(20)30107-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlessi, Joao V | |
| 245 | 0 | 0 |
_aImmunotherapy in lung cancer: effective for patients with poor performance status? _h[electronic resource] |
| 260 |
_bThe Lancet. Respiratory medicine _c09 2020 |
||
| 300 |
_a838-839 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aCarcinoma, Non-Small-Cell Lung |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aLung Neoplasms |
| 700 | 1 | _aAwad, Mark M | |
| 773 | 0 |
_tThe Lancet. Respiratory medicine _gvol. 8 _gno. 9 _gp. 838-839 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S2213-2600(20)30107-7 _zAvailable from publisher's website |
| 999 |
_c30767994 _d30767994 |
||